Imagyn Revising Internet Website Following FDA Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
Imagyn Medical Technologies plans to have a revised website back online by April 1. The site was pulled by the company in response to a March 6 warning letter from FDA which cites statements about the firm's Ovation falloposcopy system that the agency deems to fall outside of approved labeling for the device.